Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) saw a large decrease in short interest in June. As of June 30th, there was short interest totalling 8,700 shares, a decrease of 28.7% from the June 15th total of 12,200 shares. Based on an average trading volume of 20,700 shares, the short-interest ratio is presently […]
Related Keywords
, Nasdaq , Geode Capital Management , Ep Wealth Advisors , Lixte Biotechnology Holdings Inc , Ethos Financial Group , Lixte Biotechnology Company Profile , Renaissance Technologies , Lixte Biotechnology Holdings , Get Free Report , Biotechnology Stock Down , Lixte Biotechnology , Capital Management , Financial Group , Biotechnology Holdings , Lixte Biotechnology Daily , Nasdaq Lixt , Zblixt , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.